Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7  by Yanagita, Masahiko et al.
Volume 311, number 1, 55-59 FEB$11627 
© 1992 Federation ofEuropean Biochemical Societies 00145793/92/$5.00 
October 1992 
Processing of mutated proinsulin with tetrabasic cleavage sites to 
bioactive insulin in the non-endocrine ceil line, COS-7 
Masahiko Yanagita", Kazuhisa Nakayama b and Toshiyuki  Takeuchi" 
"Dlvlsion of Molecular Endocrinology, Institute for Endocrblology, Gunma University, Maebashi 371, Japan and bGene Experiment 
Center, UniverMty of Tsukuba, lbaraki 305, Japan 
Received 11 August 1992 
The amino acid sequence, Arg-"-X-LLy~Arg-"-Arg -t ~ X *t, is thought to be a concensus processing site for a constitutive s cretory pathway in
non-endocrine c lls. We created a mutant proinsulin DNA with a peptide structure of B chain-Arg.Arg-Lys.Arg-C pcptid¢-Arg-Arg-L~-Arg-A 
chain, which compares tothe native proinsulin structure ofB chain-Arg-Arg-C peptide-Lys-Arg-A chain. When the mutant insulin wa~ expressc.d 
in a monkey kidney.derived cell line. COS-7, approximately 60% of the total immunoreactive insulin appeared as mature insulin in the cultur~ 
medium. This conversion tothe mature form was strikingly facilitated by co-expressing the mutant proinsulin with furin, a homoiogu¢ ofthe y~ast 
endoprotaase, K x2. 
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1. INTRODUCTION 
Insulin is produced in pancreaticfl-cells a the precur- 
sor, proinsulin, comprising three peptides linked by two 
pairs of basic residues in the following order: B chain- 
Arg-Arg-C peptide-Lys-Arg-A chain [1,2]. C peptide is 
cleaved off from proinsulin at the adjacent dibasic resi- 
dues during its transport hrough the trans-Golgi net- 
works to immature-type secretory vesicles [3,4]. The 
conversion from proinsulin to insulin is a unique func- 
tion of endocrine cells [5]. A number of propeptide 
hormone cDNAs, including a human proinsulin cDNA, 
have been introduced into both endocrine and non- 
endocrine ceils (reviewed in [6]), and those expressed in 
endocrine cells were generally processed correctly, while 
those expressed in non-endocrine cells were secreted 
constitutively as non-cleaved propeptides [5]. However, 
the inability of non-endocrine c lls to convert proinsulin 
to insulin does not mean they ..re also unable to process 
other propeptides to smaller bioactive peptides. Non- 
endocrine cells, including fibroblasts, hepatocytes, and 
lymphocytes, produce biologically inactive propeptides 
and convert them to bioactive peptides by cleaving a 
unique consensus sequence, Arg-4-X-a-Lys/Arg -2- 
Arc -t $ X +~ [7]. In addition to this consensus sequence, 
a processing site with one more basic amino acid at 
position -3  was noted in several precursor proteins, 
including insulin receptor A chain and B chain, comple- 
ment components C3 d- and a chain, C4 d- and 0~ chain, 
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and C4 0c-and 7 chain [8-10]. The protoolysis of the 
insulin receptor A chain-Arg-*-Lys-3-Arg-2-Arg-t-B 
chain is carried out at the tetrabasic re~id)tes, resulting 
in the functionally active receptor A chain-S-$-B chain. 
The insulin receptor with the mutated tetrabasic proc- 
essing site, Arg-~-Lys-3-Arg--~-Ser -~, was identified in a 
diabetic patient with the type A syndrome of severe 
insulin resistance [l 1]. It was proved that the insulin 
binding affinity to this mutated receptor was markedly 
decreased, thus proteolytic processing at the tetrabasic 
residues is an absolute requirement for the attainment 
of full receptor function. 
Proteolytic cleavage of the consensus sequence, 
Arg -4- X-LLys/Arg'-'-Arg -t ~ X *~. is catalyzed by the 
subtilisin-like endoprotease, furin [12,13]. Furin was 
originally identified as a homologue of the yeast 
propeptide-processing eadoprotease, Kex2, and is 
thought o be a mammalian endoprotease in non-endo- 
crine cells [14,15]. Furin has been demonstrated to be 
present in virtually all non- endocrine cells, including 
fibroblasts, epithelial cells and lymphocytes [15]. 
By utilizing the above information we constructed a 
mutant rat proinsulin DNA with a peptide structure 
of B chain-Arg-Arg-Lys-Arg-C peptide-Arg-Arg-Lys- 
Arg-A chain, with the expectation that a non-endocrine 
cell line, COS-7, would be able to convert his mutant 
proinsulin to mature bioactive insulin. In the event hat 
the conversion to mature insulin was not sufficient, we 
planned to co-express a furin eDNA together with a 
mutant proinsulin DNA to boost the conversion. In this 
paper we demonstrated that the co-expression of  both 
DNAs in COS-7 cells attained virtually 100% of conver- 
sion from proinsulin to insulin. 
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2. MATERIALS AND METHODS 
2,1. Construction of the mttive and mutant in,~'ulin DNAs 
For the expression of native and mutant insulin, we utilized a rat 
insulin I gone 116], which comprises two exons, and one intt'on that 
is located 14 bp ahead of the initiation eodon, ATG. This gene lacks 
a second intron in the middle of the DNA sequence corresponding to
C peptide, unlike rat insulin gen¢ II and insulin genes from other 
mammals [17], The whole proinsulin-coding DNA sequence of 350 bp 
was obtained from this gene using a site-directed in vitro mutagenesis 
s~,stem kit (Takara, Kyoto) described as Ibllows, At first a 1,1 kb 
P,~'ti-Xbal fragment of rat insulin I gene [16] was inserted into a M I3 
mpl9 bacteriophage v ctor, The oligonueleotide primers used for the 
mutagencsis are depicted in Fig, 1, All oligonucleotides were synthe- 
sized using an Applied Biosystems Model 391 PCR-Mate DNA syn- 
thesizer. Tile BatnH! restriction sites were introduced 4 bp upstream 
of the initiation codon, ATG, and 7 bp downstream of the stop eodon, 
TGA, adjacent o the insulin coding sequence, Mutant clones were 
identified directly by DNA sequencin8 with the dideoxynucleotide 
method. Double-stranded DNA was then prepared from a mutated 
MI3 clone, and a 350 bp length of mutated rat insulin DNA was 
isolated with BamHl digestion and cloned into the BamHI site of the 
pGEM 3Zf(.e) vector (Promega, Madison. Wi). The direction of the 
insert was determined by DNA sequencing. The vector containing the 
insulin DNA in the sense dir~tion was digested with Pstl and EcoRI. 
and subcloned into the Pstl and EcoRI sites of a pcDL-SRa296 ex- 
pression vector [18]. Both native and mutant insulin expression vector 
constructs were purified twice by cesium chloride gradient centrifuga- 
tion. The pSVDFur expression vector construct containing a furin 
cDNA [15] was prepared in tile same manner. 
2,2, Cell culture and DNA trnn~fection 
COS-7 cells were cultur~ in Dulbeceo's modified Eagle's medium 
(Sigma. St Louis, Me)  supplemented with 10% fetal bovine serum 
(Gibeo. Grand Island, NY) at 37°C in 5% CO~, Transfcetions of the 
expression vector constructs into tile ¢¢11s were carried out by electro- 
poration using a Gene Pulser (Bio-Rad, Richmond. CA), Cells were 
allowed to 8row to near confluence in a 100 mm dish. The cells were 
washed once with PBS buffer (Ca:'- and Mg :* free), harvested with 
0,05% trypsin/0,02% EDTA, and then resuspended in PBS buffer at 
a concentration of 2×107 cells/ml. A cell suspension of 0,tl ml with 1S 
mg of an expression w.~:tor construct was tran'¢erred to an electropo- 
ration ¢uvette (Bio-Rad), Thecuvette was placed on ice for 5 rain. and 
then ¢leetroporated at a setting of 309 V and 500,uF, The cells were 
allowed to recover on ice Ibr 10 min and then divided into tour 100 
mm dishes containing the culture medium. 12 h after the electropora- 
tion, culture medium was removed and the cells were incubated in 
fresh medium with 5% fetal bovine serum for 72 h, Every 24 h the 
culture medium was collected for insulin radioimmunoassay, In the 
go-expression experiment the proinsulin DNA and the furin eDNA 
constructs were mixed at the same molar ratio, then the eleetropora- 
tion of the DNA mixture was carried out in the same manner. 
2,5, Glucose transport analysis 
Glucose transport activity of fat cells stimulated by insulin was 
assessed by measuring the rate of uptake of 3-O-methyl-D-glucose at 
37°C according to the 3.s method of Whitesell and Gliemann, and 
modified by Toyoda et al. [19], Adipocytes were isolated by ¢ollage- 
nase digestion from a rat epididymal adipose tissue, Approximately 
10 rag of adipocytes, measured by a hematocrit tube, were incubated 
with 100/~M 3-O-[~H]methyl-t~-glucose (10 mCi/ml) in the presence or 
absence of insulin Ibr 3 s at 37°C in a total volume of 100/~1. The 
reaction was terminated by adding 300 pl of 1 mM phloretin, an 
inhibitor Ibr glucose transport, and cells in 300 ld of the suspension 
were collected by the oil-flotation method ofGliemann et el, [20]. The 
amount of glucose in the extracellalar space was determined by adding 
labeled 3-O.methyl-rJ-Blucose after adding phloretin. The radioactiv- 
ity in the cell fraction was determined ina liquid scintillation counter. 
3. RESULTS 
3.1. Expression oj' the native and mutant pro#zsulin in 
COS- 7 cells 
Each proinsulin DNA construct was transfected into 
COS-7 cells by the electroporation method. 12 h after 
the electroporati~n, the culture medium was removed 
and the cells were incubated in fresh medium. The cul- 
ture medium was collected every 24 h from the point of 
this medium change up to 72 h. Comparing the im- 
munoreactive insulin (IR1) secreted into the culture me- 
dium during the first 24 h from native and mutant pro- 
insulin-expressed ceils, one can note that IRI from the 
mutant proinsttlin-expressed cells was almost half of 
that from the native proinsulin-expressed cells, as 
shown in Fig. 2. IRI in the second and third 24 h culture 
medium from the two cell groups showed exactly the 
same tendency. Interestingly we constantly observed the 
lower production of mutant proinsulin in other cell lines 
(data not shown). IRI from the mutant proinsulin-ex- 
pressed cells, however, was still 5-fold higher than that 
fi'om the rat insulinoma cell line, RINmSF [21], as 
shown in Fig. 2. A small amount of IRI was also de- 
tected in cell extracts of transfected COS cells. However, 
it was only 1-2% of the IRI in the culture medium, as 
was observed in the case of progastrin expressed in 
fibroblasts [22]. Since COS cells do not contain secre- 
tory granules, peptides must be released into culture 
medium as soon as they are synthesized. 
2,3. Radlohnnmnoassay 
lmmunoreactive insulin in the culture medium and the solution 
fraetionated lay gel filtration chromatography was determined using 
an insulin immunoassay kit (Amersham Japan. Tokyo). according to 
the manufacturer's instruction. 
2.4. Gel filtratlon 
Gel filtration was performed with a 1,0 x 120 cm column (Bio-Rad) 
of a Sephadex G-50 superfine gel (Pbarmaeia LKB, Piseataway, NJ) 
equilibrated with 50 mM sodium acetate lution buffer (pH 5,0) for 
analysis of" the apparent size of insulin secreted into the culture me- 
dium. The medium was lyophifized and then dissolved in the elmion 
buffer and then applied to the column. Fractions or 1,5 ml were 
routinely collected, Size calibration wa.~ carried out with blue dextran 
(Vo) and potassium ferrlcyanide (V,). 
3.2. Processhrg of native and nnttant proinsulin fit COS.7 
ceUs 
We next examined the extent of conversion from pro- 
insulin to mature insulin in the native and mutant pro- 
insulin-expressed cells. The culture medium from each 
cell group was subjected to gel filtration on a Sephadex 
G-50 column. When the culture medium of  tim native 
proinsulin cells was applied to this gel, IR1 was eluted 
first at the proinsulin position, followed by a small peak 
corresponding to the mature insulin position, as de- 
picted in Fig. 3a. This result was unexpected since 
Moore et ai. [5] reported the production of haman pro- 
insulin without ally processed insulin from a mouse 
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Fi~. i. The nucleotide and amino acid sequences across the two processing sites on native and mutant proinsuiin. Upper sequencea represent the 
nucleotide s quence and its corresponding amino acid sequence ofnative rat proinsulin. Lower sequences depict the two oligonucleotides utii"ggd 
for the site-directed mutagenesis experiment, the nueleotide s quence and its corresponding amino acid sequence. The replaced aucl¢otidgs and 
basic residues inbold type. Nrul and BssHll restriction sites were created to facilitate identification fthe mutated proinsulin DNA. 
fibroblast-derived cell line (Ltk- cells). At first we 
thought he IRI at the mature insulin position might be 
converted from proinsulin after the secretion into the 
culture medium. We pooled the proinsulin fraction and 
incubated it with non-transfected COS-7 cells over 24 
h. Re-application of the culture medium onto the same 
column exhibited a single proinsulin peak, again with- 
out the appearance of a new IRI peak at the mature 
insulin position. We then noticed from amino acid se- 
quence of the processing sites on rat proinsulin that 
both sites of rat proinsulin were somehow matched to 
the consensus proteolytic leavage sequence of non-en- 
docrine cells (Arg-4-X-3-Lys/Arg--~-Arg-I J, X*~), while 
one of the two on the human proinsulin sequence was 
not, as described in section 4 (Fig. 1). 
The culture mediuln from the mutant proinsulin-ex- 
pressed cells demonstrated two peaks on a Sephadex 
G-50 gel filtration chromatography, one at the proin- 
salin position and the other at the mature insulin posi- 
tion, as depicted in Fig. 3b. The ratio of mature insulin 
to total IRI was approximately 60%. Thus, we realized 
that the creation of the tetrabasic processing sites on the 
proinsulin sequence was not sufficient for full conver- 
200 
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Fig. 2. Comparison of the hnmunoreactive insulin (IRI) production 
from the native and mutant proinsulin-expressed CO8-7 c~lls, and 
from RINmSF cells. 12 h after el~tropo,"ation, cultur= m~ium was 
collect~ every 24 h lbr 72 h for insulin radioimmunoassay. This figure 
depicts IRI in the first ofthe 24 h samples. The bars represent the mean 
~2 S.D. 
sion of proinsu;~:n to mature insulin. Thus, we co-ex- 
pressed furin, which is thought to be a mammalian 
processing endoprotease in non-endocrine cells, to- 
gether with native or mutant proimulin. As depicted in 
Fig. 3d, co-expression o£ furin and mutant proinsulin 
resulted in the complete conversion of proinsulin to 
mature insulin, and did not leave any trace amount of  
lg l  at the proinsulin position. Co-expression of furin 
together with native proinsulin also facilitated further 
conversion of proinsulin to mature insulin (Fig. 3c). In 
this case, a little over 50% of the total 1gl appeared at 
the mature insulin position. 
3.3. Bioactivio, of mature insulin from COS-7 cells 
We further examined its biological activity by meas- 
uring the incorporation of 3-O-[3l-I]methylglucos¢ to ad- 
ipocytes. Adipoeytes were collected after the digestion 
ofepididymal adipose tissue with eollagenase, and incu- 
bated with 3-O-[3H]methylglucos¢ for 3 s in the presence 
of insulin. As depicted in Fig. 4, insulin from the mutant 
proinsulin-expressed cells (filled bars) exhibited a simi- 
lar biological activity to the synthetic human insulin 
(hatched bars) at two different insulin concentrations 
(25 and 90 pM). Therefore, the insulin from COS-7 cells 
was fully functional from the aspect of its glucose up- 
take capability. 
4. DISCUSSION 
A decade ago, Gruss and Khoury [23] expressed rat 
proinsulin in monkey kidney cells by inoculating the 
recombinant SV 40 DNA construct that replaced the rat 
insulin I gene in the late region of a SV-40 vector, with 
a temperature-sensitive helper virus. Lomedico [24] suc- 
ceeded in producing rat proinsulin by traasfceting a SV 
40 early region-rat insulin I1 gene DNA construct o 
COS cells. Since then, many investigators have used this 
heteroiogous cell expression system for studying proc- 
essing of peptide precursors [6]. Moore et al. [5] ex- 
pressed human proinsulin in a mouse anterior pituita,~,- 
derived cell line, ART20 cells, and in a mouse fibroblast- 
derived cell line, Ltk-cells. Proinsulin was correctly 
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Fig, 3, Gel filtration profiles of IRI in the culture medium of native 
and mutant proinsulin.expres~ed COS cells. The concentrated media 
were applied to Sephadex G-50 superfine columns (I.0 × 120 era) 
equilibrated in acetate buffer, pH 5,0, Fractions of 1.5 ml were col- 
lected and measured for IRI by radioimmunoassay, Molecular size 
was calibrated with blue dextran (Vo), potassium ferrieyanide (VJ and 
synthetic human insulin, Similar elution profiles were obtained in at 
least three other chromatographs foreach experiment. (a) IRI in the 
medium from the native proinsulin.expressed c lls; (b) IRI in the 
medium from the mutant proinsulin.ezpressed c lls; (c) IRI in the 
medium from the native proinsulin and furin-co-expressed cells; (d) 
IRI in the medium from the mutant proinsulin and furln-eo-expressed 
cells, 
processed to mature insulin in the endocrine cell line, 
AtT20, while it remained as proinsulin in the fibroblast 
cell line, Ltk-. Generally production of unprocessed 
propeptides has been observed when foreign pro- 
hormone genes are expressed in non-endocrine cell 
lines. However, Warren and Shields [25] and Sevarino 
et al. [26] observed correctly cleaved somatostatin i  the 
non-endocrine c ll lines, COS-7 and 3T3-Swiss-Albino, 
respectively, although the cleaved fraction was very 
small compared to the uncleaved somatostatin precur- 
sor fraction. Later, Stoller and Shields [27] altered the 
paired basic amino acid processing site, Arg-Lys, of 
prosomatostatin to Lys.Arg attd Arg-Arg, and ex- 
pressed the native and mutated precursors in the rat 
pituitary endocrine cell line, GH3, and in the mouse 
non-endocrine c ll line, 3T3. The processing site of na- 
tive prosomatostatin is composed of Arg-4-Glu -3- 
Arg-2-Lys "*, which shows only one amino acid differ- 
ence at position -1 from the non-endocrine c ll consen- 
sus processing site Arg-4-X'3-Lys/Arg --~- Arg- $ X +l. 
Lysine at position -1 is also a basic amino acid, thus 
it is not surprising that native prosomatostatin was 
processed to somatostatin to some degree in COS and 
3T3 cells. As expected, the mutated precursor with the 
non-endocrine cell consensus processing site, Arg -4- 
Glu-3-Lys-2-Arg -t or Arg-%Glu'3-Arg:--Arg -t was 
processed to the 14 amino acid somatostatin more effi- 
ciently than the native precursor in 3T3 cells. More 
recently partial cleavage of the neuropeptide Y precur- 
sor was reported in transfected Chinese hamster ovary 
cells [28]. This cleavage is also explained by the resem- 
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Fig. 4. Incorporation of 3-O-[~H]methylglucose to adipocytes stimu- 
lated by mature insulin from the mutant proinsulin-expressed c lls. (a. 
hatched bars) Synthetic human insulin; (b, filled bars) mature insulin 
fraction from the mutant proinsulin-expressed c lls. 
blance of the precursor processing site to the concensus 
processing site of non-endocrine c lls. 
As described above, Moore et al. [5] reported that 
human proinsulin was not processed in a mouse fibro- 
blast-derived cell line, Ltk-. In our experiment, rat na- 
tive proinsulin was processed to a small e~tent to insulin 
in COS-7 cells (Fig. 3a). We do not think this is due to 
the difference of cell lines used in each experiment. By 
comparing the amino acid sequences of human and rat 
proinsulin processing sites in Fig. 1, we noted that the 
junction sequence between the C peptide and the A 
chain is Leu-GIn-Lys-Arg in human proinsulin and 
Arg-Gln-Lys-Arg in rat proinsulin I [29], which is per- 
fectly matched to the non-endocrine cell consensus 
processing site, Arg-4-X-3-Lys/Arg-:-Arg -~ ~ X +~. Since 
the other junction sequence is Lys-Thr-Arg-Arg in 
human proinsulin and Lys-Ser-Arg-Arg in rat proin- 
sulin I [29], and Lys at the -4  position is also a basic 
amino acid, it is not surprising to observe processed 
insulin in the rat proinsulin expression experiment, as 
is the case of prosomatostatin o somatostatin conver- 
sion in COS cells [25]. 
The cleavage of the consensus sequence is thought o 
be catalyzed by the subtilisin-like ndoprotease furin. 
Furin was identified by homology to the yeast endopro- 
tease, Kex2o and is believed to represent a mammalian 
cell processing enzyme [14,15]. All cell lines so far exam- 
ined contain some amount of furin, although its content 
is different from cell to cell [15]. COS cells appeared to 
contain less furin compared with other cell lines by 
Northern blot analysis (unpublished ata). Thus, ex- 
pression of mutant proinsulin itself in COS cells might 
not attain complete conversion to mature insulin with- 
out a boost of furin co-expression. The mature insulin 
from COS cells presented a similar biological activity to 
the synthetic human insulin in terms of its [3H]meth- 
ylglucose incorporation ability to adipocytes. We are 
currently in the process of expressing insulin perma- 
Volume 311, number 1 FEBS LETTERS October 1992 
nently in other non-endocr ine cells o f  different origin to 
investigate the processing efficiency o f  tetrabasic sites in 
these cells. 
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